The response was pretty overwhelmingly positive when I started sending out those “Trade Note” emails this week… so I’ll stick with it for a while, at least, and see how this goes. What does that mean? Same day buy/sell notes about my Real Money Portfolio will be sent to the Irregulars going forward, in hopes […]
Articles
- Most Relevant
- Most Recent
Yesterday we dug into the teaser pitch for Blue Chip Gems that promised Bret Jensen’s “#1 Forever Stock for 2016,” and I told you I’d try to also name his other two picks… … so that’s today’s goal, identifying those other two members of Jensen’s “Top 3 Buy and Hold ‘Forever Stocks’” portfolio. We don’t […]
Sometimes it seems like investment newsletter teasers run in trends… last week we were inundated with “smart metal” pitches, this week the questions are pouring in about Doug Casey’s “Super Metal.” I guess we shouldn’t be surprised, so many newsletter ads try to implant a short little phrase in your head that harnesses their investing […]
The idea that we’re finally going to enter an era of just and profitable growth in Africa (or at least, sustainable growth) has been around for a long time, and it’s been wrong for a long time, as Africa has arguably been subject to more exploitation, poverty, and human suffering than your average continent over […]
Today we’re again hearing from old friend Christian DeHaemer (“old friend” as in, “don’t even know what he looks like and have never spoken to him but read lots of his ads”) — he’s selling his BreakAway Investor newsletter with this pitch … “On March 31st, 2009, The “EMN Initiative” Goes Live “A Historic Government […]
Don’t worry, we haven’t just been sitting around here at Gumshoe HQ, waiting for the Fifth Coming … in fact, although I may have an itchy “buy” finger to upgrade my own iPhone when this new one becomes available next week, I’ve spent the day looking into something completely different. Porter Stansberry has been blanketing […]
Zach Scheidt is pitching his Lifetime Income Report ($49) newsletter by hinting at some more big 5G winners — and while there’s probably not a whole lot new in the four stocks he’s teasing, since most of the 5G stocks have been discussed to death as we wait for the surge of next-generation profits to […]
I’ve been so overwhelmed with gold and silver teases, and have written about them so many times over the last couple weeks, that I was really prepared to jump on anything that looked a bit more like a “real” company (ie, not just a commodity play or a hyped-up junior miner) … so here comes […]
The folks at Cabot are unabashed fans of growth and momentum, which can certainly work as an investment strategy even if it isn’t the strategy I tend to follow personally … the market loves businesses that are growing, and that love turns into higher prices if the growth builds on itself, even if the stocks […]
I’ve been so overwhelmed with gold and silver teases, and have written about them so many times over the last couple weeks, that I was really prepared to jump on anything that looked a bit more like a “real” company (ie, not just a commodity play or a hyped-up junior miner) … so here comes […]
I didn’t do anything with my portfolio this week, and I don’t think we’ve had significant news that changes my opinion about any of the stocks I wrote about in our Annual Review about ten days ago, so today I’ll just dig into a teaser pitch for your Friday File edutainment. Here’s the intro to […]
There’s been a lot going on among the stocks that I own and those that I’ve written a lot about for you over the years, so I have a bit of updating to share when it comes to my thoughts … first, some thoughts on two large personal holdings that I’ve never suggested in the […]
I was just puttering around this morning, trying to decide which ebullient and/or egregious teaser ad to focus on, when a new one came rolling in across the virtual transom … and it looked like just the thing to wake a Gumshoe up, so let’s dig in! The ad is from Horacio Marquez for his […]
Today we’ve got an interesting tease that a few readers sent in — it’s from the White Cap Report folks, who generally look for potentially high-octane growth stocks, and it’s about some kind of biotech stock. Here’s how they get our blood flowing this fine morning: “California Biotech Cleared to Bypass FDA – Next Month […]
During the last few days when I was traveling to and reporting from the Value Investing Congress for the Irregulars (some great presentations, by the way, my notes from day one and day two are up now and I’m hoping to get some more thinking time in regarding these ideas soon), the most-requested teaser for […]
On this bright and cheerful Monday we’re taking a look-see at a new entrant in the newsletter world — not only because it teases a couple intriguing investment ideas and promises great gains, as they all do, but because this is the first newsletter I’ve seen that is completely focused on India. Newsletters that look […]
The idea that we’re finally going to enter an era of just and profitable growth in Africa (or at least, sustainable growth) has been around for a long time, and it’s been wrong for a long time, as Africa has arguably been subject to more exploitation, poverty, and human suffering than your average continent over […]
This week I’ve got a little teaser decipherization for you to get us started, and we’ve also got a new piece from Dr. KSS… and I’ve got some updated thoughts on a few other stocks at the end of today’s piece. The teaser? Well, it’s been circulating for a few weeks now, and it caught […]
I always feel a swell of optimism when I read a teaser ad from Patrick Cox — something about his relentless happy-facing about the teensy tiny technology and biotech companies he loves just stirs me up a little bit, reminds me that the reason many of us dabble in microcap stocks, little mining companies, new […]
These are the kind of teaser ads that always bring a smile to my face — top secret technology from “rogue” scientists, unknown breakthroughs that will change the face of the world and make us rich, that’s what teaser-land is all about! And certainly Nick Hodge knows that — all the publishers use the same […]
Most of us are self-directed investors, for good or ill — you’re probably here because you like researching or trading stocks, and I obviously feel the same. But should we be trusting ourselves to manage our money? I know that sounds like a fatuous question — obviously, we should trust ourselves much more than we […]
I’m running late today and working on a few pieces that aren’t done yet, but I don’t want to leave our fabulous Gumshoe readers with nothing to think about… so let’s get a quick teaser solution out for you. The pitch is from David Dittman for his Utility Forecaster, the conservative, income-focused newsletter that was […]
Robot WarriorGot in on a penny stock a while back just on thinking of the way the future is changing in the Dept of Defense and looking at some Hi Tech. Magazines and picked up EKSO for a .70 limit that got filled and just bought 5,000 shares and last week it ran up to $1.50 […]
[Ed. Note: Dr. KSS writes about medicine and biotech stocks for the Irregulars. This article is third in a series on pain. You can see the first part here, and second part here. His words and opinions are his own, and he has agreed to our trading restrictions. Enjoy!] It’s the stuff of bucket lists: eating fugu […]
This article was originally published on November 13, 2013. The ad is circulating again and generating questions from readers, so we’re re-running it for you — the ad is still largely unchanged, and the three “secret” companies are still the same. The largest, FANUY, has matched the S&P with a 9% gain since the article […]
Travis- I so much appreciate and enjoy you and the exceptional irregular-shoes here. I have several thoughts/ideas I’d like share: Have you ever considered: 1. A ”Beyond the decimal” (sub penny) and/or pre- and after-market discussion area(s)? 2. An investor tools link area i.e. finvis, barchart, bloomberg, otcmarkets, zacks etc, not only for links but […]
[Ed. Note: Dr. KSS writes for the Irregulars about medicine and biotech stocks. His topics, words and opinions are his own. Enjoy!] It’s the second reel of conspiracy film Shooter, and Mark Wahlberg, whom government schemers are trying to frame for assassination, has just been shot twice. In the back of a stolen FBI car, […]
Today we’re due for our “Idea of the Month” pick — but I also should quickly let you know that I personally added some more to my Lancashire Holdings position this week when it tripped a buy order that had been in place for a while. I wrote more about Lancashire in my insurance-themed “idea […]
I’d love your thoughts on Next Galaxy Corp. Used to be Wiless Controls, hovering around $0.02 a share. In past couple of months, morphed into Next Galaxy (there is a decent amount of press behind that transaction). Entering the Virtual Reality software space with supposed applications to the Oculus Rift headset (Recently purchased by FaceBook […]
During the last few days when I was traveling to and reporting from the Value Investing Congress for the Irregulars (some great presentations, by the way, my notes from day one and day two are up now and I’m hoping to get some more thinking time in regarding these ideas soon), the most-requested teaser for […]
[Ed. Note: Dr. KSS writes about medical topics and biotech stocks for the Irregulars. He choses his own topics, and his words and opinions are his own. Part one of this series is here if you missed it. Enjoy!] “The heat was hot and the ground was dry but the air was full of sound. I’ve […]
Teeka Tiwari teasers wash up on the shores of Gumshoe island every few months, though we don’t cover them all that often because he hasn’t done a lot of teasing of individual stock ideas (he has more frequently, if memory serves, pitched his trading “systems”). It looks like Tiwari’s Mega Trends is now being published […]
Hello fellow Gumshoers! In keeping with the Gumshoe process of performing due diligence for investing, I would like to share my results of a visit to Junior mining Home offices I recently visited. I work for Chevron Oil, and had the good fortune to visit beautiful Vancouver, British Columbia. Staying in downtown Vancouver afforded me […]
August 15, 2014 Dear Reader, Right now, a unique life-saving effort is underway in a sub-niche of the financial markets. If you choose to invest in this ”campaign” – as I’ll outline in a moment – your reward will be twofold… First, you’ll get the deep satisfaction of knowing your investment helped save lives – […]
Dear Reader, Today I rip the cover off my company’s secret weapon. I call him the “reluctant millionaire maker.” Talk about operating undercover. This guy’s living it. He craves privacy… he’s been lying low for the past decade… yet his Wikipedia page has 47 footnotes. What gives? For a long time, he has run in […]
Ok, this is definitely the “most requested” ad over the last 24 hours — I can’t tell you how many folks have asked your friendly neighborhood Gumshoe to look into “Living Metal,” but the list is getting loooong. And we are, of course, happy to oblige. The pitch is from Michael Robinson for his Radical […]
I might have missed it but, Travis or any irregulars that might have the scoop on the octopus technology teaser for oil drilling, we had the waterless fracking and some other techniques, it seems every drilling contractor has there preference or is it what they can afford for that part of the drilling phase but […]
That’s the headline for the latest ad from David Dittman, who inherited leadership of the Canadian Edge newsletter when Roger Conrad left for greener pastures. And I was intrigued enough to take a look — not least because he’s touting some ancillary stocks that benefit indirectly from oil money… but also because, unlike every other […]
[Ed. Note: Dr. KSS writes about medical topics and biotech stocks for the Irregulars. He has agreed to our trading restrictions, and his thoughts and words are his own. Enjoy!] Any discussion of cholesterol immediately turns Brobdingnagian, such are the extremes in question. Statins, which lower LDL cholesterol, are bombastically the best-selling drugs of all […]
Michael Robinson has been a big booster of tech ideas for his Nova-X Report, and lately he’s trying to sell his newsletter by using a special report that he says will reveal “The Wearable Tech Investment Opportunity of a Lifetime.” So naturally, Gumshoe readers want to know who it is. The spiel starts off with […]